Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2007, p. 1508-1511, Vol. 51, No. 4
0066-4804/07/$08.00+0 doi:10.1128/AAC.01517-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, Pennsylvania 17033
Received 4 December 2006/ Returned for modification 2 January 2007/ Accepted 17 January 2007
Time-kill synergy studies testing in vitro activity of DX-619 alone and with added vancomycin, teicoplanin, or linezolid against 101 Staphylococcus aureus strains showed synergy between DX-619 and teicoplanin at 12 to 24 h in 72 strains and between DX-619 and vancomycin in 28 strains. No synergy was found with linezolid, and no antagonism was observed with any combination.
Published ahead of print on 29 January 2007.
Supplemental material for this article may be found at http://aac.asm.org/.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»